These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

220 related articles for article (PubMed ID: 9973517)

  • 1. Immunostimulatory CpG-oligodeoxynucleotides cause extramedullary murine hemopoiesis.
    Sparwasser T; Hültner L; Koch ES; Luz A; Lipford GB; Wagner H
    J Immunol; 1999 Feb; 162(4):2368-74. PubMed ID: 9973517
    [TBL] [Abstract][Full Text] [Related]  

  • 2. CpG-oligodeoxynucleotides induce mobilization of hematopoietic progenitor cells into peripheral blood in association with mouse KC (IL-8) production.
    Nardini E; Morelli D; Aiello P; Besusso D; Calcaterra C; Mariani L; Palazzo M; Vecchi A; Paltrinieri S; Menard S; Balsari A
    J Cell Physiol; 2005 Sep; 204(3):889-95. PubMed ID: 15828023
    [TBL] [Abstract][Full Text] [Related]  

  • 3. CpG-containing oligodeoxynucleotides induce TNF-alpha and IL-6 production but not degranulation from murine bone marrow-derived mast cells.
    Zhu FG; Marshall JS
    J Leukoc Biol; 2001 Feb; 69(2):253-62. PubMed ID: 11272276
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The mechanism for the ameliorative effect of CpG-oligodeoxynucleotides on bone marrow hemopoiesis radiation injury.
    Zhang C; Ni J; Gao F; Sun D; Zhou C; Cheng Y; Cai J; Li B
    Basic Clin Pharmacol Toxicol; 2011 Jul; 109(1):11-6. PubMed ID: 21385323
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Potentiation of a dendritic cell vaccine for murine renal cell carcinoma by CpG oligonucleotides.
    Chagnon F; Tanguay S; Ozdal OL; Guan M; Ozen ZZ; Ripeau JS; Chevrette M; Elhilali MM; Thompson-Snipes LA
    Clin Cancer Res; 2005 Feb; 11(3):1302-11. PubMed ID: 15709202
    [TBL] [Abstract][Full Text] [Related]  

  • 6. CpG-A and B oligodeoxynucleotides enhance the efficacy of antibody therapy by activating different effector cell populations.
    van Ojik HH; Bevaart L; Dahle CE; Bakker A; Jansen MJ; van Vugt MJ; van de Winkel JG; Weiner GJ
    Cancer Res; 2003 Sep; 63(17):5595-600. PubMed ID: 14500400
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Immunostimulation and anti-DNA antibody production by backbone modified CpG-DNA.
    Kim D; Rhee JW; Kwon S; Sohn WJ; Lee Y; Kim DW; Kim DS; Kwon HJ
    Biochem Biophys Res Commun; 2009 Feb; 379(2):362-7. PubMed ID: 19103173
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hemopoietic activity in bone marrow chimeras prepared with total lymphoid irradiation (TLI).
    Slavin S; Seidel HJ
    Exp Hematol; 1982 Feb; 10(2):206-16. PubMed ID: 7037437
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Screening of novel immunostimulatory CpG ODNs and their anti-leukemic effects as immunoadjuvants of tumor vaccines in murine acute lymphoblastic leukemia.
    Wang J; Zhang W; He A; Zhao W; Cao X
    Oncol Rep; 2011 Feb; 25(2):519-29. PubMed ID: 21165566
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Stimulation of thymocyte proliferation by phosphorothioate DNA oligonucleotides.
    Mannon RB; Nataraj C; Pisetsky DS
    Cell Immunol; 2000 Apr; 201(1):14-21. PubMed ID: 10805969
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Continuous administration of Il-13 to mice induces extramedullary hemopoiesis and monocytosis.
    Lai YH; Heslan JM; Poppema S; Elliott JF; Mosmann TR
    J Immunol; 1996 May; 156(9):3166-73. PubMed ID: 8617937
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Oligodeoxynucleotides containing CpG motifs can induce rejection of a neuroblastoma in mice.
    Carpentier AF; Chen L; Maltonti F; Delattre JY
    Cancer Res; 1999 Nov; 59(21):5429-32. PubMed ID: 10554011
    [TBL] [Abstract][Full Text] [Related]  

  • 13. CpG oligonucleotides enhance the tumor antigen-specific immune response of a granulocyte macrophage colony-stimulating factor-based vaccine strategy in neuroblastoma.
    Sandler AD; Chihara H; Kobayashi G; Zhu X; Miller MA; Scott DL; Krieg AM
    Cancer Res; 2003 Jan; 63(2):394-9. PubMed ID: 12543793
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antimetastatic effect of CpG DNA mediated by type I IFN.
    Hafner M; Zawatzky R; Hirtreiter C; Buurman WA; Echtenacher B; Hehlgans T; Männel DN
    Cancer Res; 2001 Jul; 61(14):5523-8. PubMed ID: 11454702
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Targeting of immunostimulatory DNA cures experimental visceral leishmaniasis through nitric oxide up-regulation and T cell activation.
    Datta N; Mukherjee S; Das L; Das PK
    Eur J Immunol; 2003 Jun; 33(6):1508-18. PubMed ID: 12778468
    [TBL] [Abstract][Full Text] [Related]  

  • 16. CpG oligodeoxynucleotides down-regulate macrophage class II MHC antigen processing.
    Chu RS; Askew D; Noss EH; Tobian A; Krieg AM; Harding CV
    J Immunol; 1999 Aug; 163(3):1188-94. PubMed ID: 10415013
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Analysis of cellular and humoral mechanisms of the anti-radiation action of the drug HC-1539].
    Lebedev VG; Vorotnikova TV; Deshevoĭ IuB
    Patol Fiziol Eksp Ter; 1994; (3):20-2. PubMed ID: 7824336
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Implication of macrophages in tumor rejection induced by CpG-oligodeoxynucleotides without antigen.
    Auf G; Carpentier AF; Chen L; Le Clanche C; Delattre JY
    Clin Cancer Res; 2001 Nov; 7(11):3540-3. PubMed ID: 11705874
    [TBL] [Abstract][Full Text] [Related]  

  • 19. In vivo immunostimulatory effects of CpG ODN in newborn piglets.
    Linghua Z; Xingshan T; Fengzhen Z
    Mol Immunol; 2007 Feb; 44(6):1238-44. PubMed ID: 16908068
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Enhanced proliferation of functionally competent bone marrow cells in different strains of mice treated with swainsonine.
    Oredipe OA; Furbert-Harris PM; Laniyan I; Green WR; White SL; Olden K; Parish-Gause D; Vaughn T; Griffin WM; Sridhar R
    Int Immunopharmacol; 2003 Mar; 3(3):445-55. PubMed ID: 12639822
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.